Home » FDA Grants Study of Abiomed Heart Device
FDA Grants Study of Abiomed Heart Device
Cardiac medical device maker Abiomed Inc. has won conditional approval from the U.S. Food and Drug Administration for a pilot study to test its Impella 2.5 device reducing heart muscle damage in patients with ST-elevation myocardial infarction.
Mass High Tech
Mass High Tech
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May